{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:12:19Z","timestamp":1791994339372,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.eclinm.2026.104122","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T05:35:42Z","timestamp":1785476142000},"page":"104122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Circulating tumor DNA in gastrointestinal cancers: promise, pitfalls, and the path forward"],"prefix":"10.1016","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-3896","authenticated-orcid":false,"given":"Sarbajit","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Sarfraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyaw Lin","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manmeet Singh","family":"Ahluwalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"19","key":"10.1016\/j.eclinm.2026.104122_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13194743","article-title":"Role of circulating tumor DNA in gastrointestinal cancers: current knowledge and perspectives","volume":"13","author":"Moati","year":"2021","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104122_bib2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1200\/OP.24.00167","article-title":"Clinical applications of circulating tumor DNA profiling in GI cancers","volume":"20","author":"Battaglin","year":"2024","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"10.1016\/j.eclinm.2026.104122_bib3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.4143\/crt.2022.1026","article-title":"Clinical circulating tumor DNA testing for precision oncology","volume":"55","author":"Kim","year":"2023","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104122_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/clinchem\/hvad188","article-title":"A practical approach to interpreting circulating tumor DNA in the management of gastrointestinal cancers","volume":"70","author":"Allan","year":"2024","journal-title":"Clin Chem"},{"issue":"9","key":"10.1016\/j.eclinm.2026.104122_bib5","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s11912-025-01701-2","article-title":"The role of circulating tumor DNA in patients treated with adjuvant immune checkpoint inhibitors: clinical reality or distant horizon?","volume":"27","author":"Maffezzoli","year":"2025","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"10.1016\/j.eclinm.2026.104122_bib6","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat Med"},{"issue":"17_suppl","key":"10.1016\/j.eclinm.2026.104122_bib7","doi-asserted-by":"crossref","first-page":"LBA3500","DOI":"10.1200\/JCO.2026.44.17_suppl.LBA3500","article-title":"Disease-free survival (DFS) and time to recurrence (TTR) with circulating tumor (ct) DNA\u2013based decision for adjuvant treatment in colon cancer stage II (CIRCULATE): an AIO (KRK-0217)\/ABCSG trial","volume":"44","author":"Folprecht","year":"2026","journal-title":"J Clin Oncol"},{"issue":"24","key":"10.1016\/j.eclinm.2026.104122_bib8","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1056\/NEJMoa2200075","article-title":"Circulating Tumor DNA analysis guiding adjuvant therapy in stage II Colon cancer","volume":"386","author":"Tie","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104122_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12916-023-03037-9","article-title":"Additional considerations before using a ctDNA-guided approach for informing adjuvant chemotherapy in colorectal cancer","volume":"21","author":"Olivier","year":"2023","journal-title":"BMC Med"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104122_bib10","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1038\/s41591-025-04030-w","article-title":"Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2\/3 DYNAMIC-III trial","volume":"31","author":"Tie","year":"2025","journal-title":"Nat Med"},{"issue":"3_suppl","key":"10.1016\/j.eclinm.2026.104122_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.2024.42.3_suppl.5","article-title":"Phase II results of circulating tumor DNA as a predictive biomarker in adjuvant chemotherapy in patients with stage II colon cancer: NRG-GI005 (COBRA) phase II\/III study","volume":"42","author":"Morris","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104122_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","article-title":"Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer","volume":"29","author":"Kotani","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.eclinm.2026.104122_bib13","doi-asserted-by":"crossref","DOI":"10.1200\/PO.22.00177","article-title":"Spontaneous fluctuations of tumor-informed circulating tumor DNA at low levels","volume":"6","author":"Dayyani","year":"2022","journal-title":"JCO Precis Oncol"},{"issue":"20","key":"10.1016\/j.eclinm.2026.104122_bib14","doi-asserted-by":"crossref","first-page":"5586","DOI":"10.1158\/1078-0432.CCR-21-0410","article-title":"Minimal residual disease detection using a plasma-only circulating tumor DNA assay in patients with colorectal cancer","volume":"27","author":"Parikh","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"3_suppl","key":"10.1016\/j.eclinm.2026.104122_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1200\/JCO.2021.39.3_suppl.11","article-title":"Circulating tumor DNA analysis for assessment of recurrence risk, benefit of adjuvant therapy, and early relapse detection after treatment in colorectal cancer patients","volume":"39","author":"Henriksen","year":"2021","journal-title":"J Clin Oncol"},{"issue":"346","key":"10.1016\/j.eclinm.2026.104122_bib16","doi-asserted-by":"crossref","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104122_bib17","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1001\/jamaoncol.2019.3616","article-title":"Circulating tumor DNA analyses as markers of recurrence risk and benefit of adjuvant therapy for stage III Colon cancer","volume":"5","author":"Tie","year":"2019","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.eclinm.2026.104122_bib18","doi-asserted-by":"crossref","first-page":"e2452661","DOI":"10.1001\/jamanetworkopen.2024.52661","article-title":"Circulating tumor DNA testing in curatively resected colorectal cancer and salvage resection","volume":"7","author":"Ji","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104122_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100547","article-title":"Minimal residual disease in gastroesophageal adenocarcinoma: the search for the invisible","volume":"7","author":"Tarazona","year":"2022","journal-title":"ESMO Open"},{"issue":"1","key":"10.1016\/j.eclinm.2026.104122_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18010094","article-title":"Personalizing treatment for pancreatic ductal adenocarcinoma: the emerging role of minimal residual disease in perioperative decision-making","volume":"18","author":"Theocharopoulos","year":"2025","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.eclinm.2026.104122_bib21","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1158\/1078-0432.CCR-24-0226","article-title":"Tissue-Free liquid biopsies combining genomic and methylation signals for minimal residual disease detection in patients with early colorectal cancer from the UK TRACC Part B Study","volume":"30","author":"Slater","year":"2024","journal-title":"Clin Cancer Res"},{"issue":"22","key":"10.1016\/j.eclinm.2026.104122_bib22","doi-asserted-by":"crossref","first-page":"6135","DOI":"10.1158\/1078-0432.CCR-21-1982","article-title":"EpiPanGI dx: a cell-free DNA methylation fingerprint for the early detection of gastrointestinal cancers","volume":"27","author":"Kandimalla","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104122_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41568-025-00795-x","article-title":"Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection","volume":"25","author":"Bruhm","year":"2025","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"10.1016\/j.eclinm.2026.104122_bib24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/oncolo\/oyae155","article-title":"Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma","volume":"29","author":"Botta","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.eclinm.2026.104122_bib25","article-title":"Circulating tumor DNA in cholangiocarcinoma: current clinical applications and future perspectives","volume":"13","author":"Wang","year":"2025","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10.1016\/j.eclinm.2026.104122_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers18050754","article-title":"Circulating Tumor DNA-Based assessment of minimal residual disease in colorectal cancer: prognostic and predictive implications","volume":"18","author":"Ozluk","year":"2026","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104122_bib27","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/ijc.33312","article-title":"Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: individual patient pooled analysis of three cohort studies","volume":"148","author":"Tie","year":"2021","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.eclinm.2026.104122_bib28","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1245\/s10434-023-14860-y","article-title":"Circulating Tumor DNA in the immediate postoperative setting","volume":"31","author":"Efthymiou","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.eclinm.2026.104122_bib29","article-title":"Incorporating circulating tumor DNA testing into clinical trials: a position paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group","volume":"9","author":"Rajdev","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.eclinm.2026.104122_bib30","doi-asserted-by":"crossref","DOI":"10.1177\/15330338251317094","article-title":"Shedding light on the prognostic and predictive value of circulating tumor DNA for management of patients with early-stage Colon cancer","volume":"24","author":"Yanes","year":"2025","journal-title":"Technol Cancer Res Treat"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537026003755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T08:30:55Z","timestamp":1787560255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537026003755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"alternative-id":["S2589537026003755"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104122","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating tumor DNA in gastrointestinal cancers: promise, pitfalls, and the path forward","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2026.104122","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104122"}}